Swiss Life Asset Management Ltd
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1637689
Zurich, V8
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$17,596,298
-$5,988,537 QoQ
Shares Held
28,220
-7.6% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#228
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $122,705,584 across 67 Biotechnology names. REGN ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,614 | $45,507,422 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
28,220 | $17,596,298 | |
| 3 | INCY |
Incyte Corp
|
104,901 | $11,891,577 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,327 | $8,828,306 | |
| 5 | RPRX |
Royalty Pharma plc
|
136,283 | $7,641,386 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,736 | $3,321,598 | |
| 7 | INSM |
INSMED Inc
|
27,552 | $2,937,594 | |
| 8 | MRNA |
Moderna, Inc.
|
25,088 | $1,756,912 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,596,298 | 28,220 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $23,584,835 | 30,525 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,306,864 | 10,762 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $13,302,182 | 23,658 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $5,857,950 | 11,158 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $6,598,528 | 10,404 | Shares | Sole | 2025-12-02 | |
| 2024-12-31 | $6,537,764 | 9,178 | Shares | Defined | 2025-12-09 | |
| 2024-09-30 | $10,159,182 | 9,664 | Shares | Defined | 2025-12-09 | |
| 2024-06-30 | $8,374,606 | 7,968 | Shares | Defined | 2025-12-09 | |
| 2024-03-31 | $6,070,424 | 6,307 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $16,357,272 | 18,624 | Shares | Sole | 2025-12-09 | |
| 2023-09-30 | $22,755,666 | 27,651 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $13,224,009 | 18,404 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $16,114,591 | 19,612 | Shares | Sole | 2025-12-09 | |
| 2022-12-31 | $9,704,761 | 13,451 | Shares | Defined | 2025-12-09 | |
| 2022-09-30 | $8,616,385 | 12,508 | Shares | Sole | 2025-12-09 | |
| 2022-06-30 | $8,671,877 | 14,670 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $13,554,934 | 19,408 | Shares | Defined | 2025-12-09 | |
| 2021-12-31 | $13,091,409 | 20,730 | Shares | Defined | 2025-12-29 | |
| 2021-09-30 | $10,032,068 | 16,577 | Shares | Defined | 2025-12-29 | |
| 2021-06-30 | $8,158,593 | 14,607 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $8,009,313 | 16,928 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $7,916,239 | 16,386 | Shares | Defined | 2025-12-29 | |
| 2020-09-30 | $5,461,772 | 9,757 | Shares | Sole | 2025-12-29 | |
| 2020-06-30 | $6,368,713 | 10,212 | Shares | Defined | 2025-12-29 | |
| 2020-03-31 | $1,391,138 | 2,849 | Shares | Sole | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||